申请人:VIRGINIA COMMONWEALTH UNIVERSITY
公开号:EP1693366A1
公开(公告)日:2006-08-23
Compounds which have enhanced affinity and selectivity for 5-HT6 receptors have been identified. These compounds can be used therapeutically in the treatment of mental disorders via administration in a pharmacologically acceptable delivery route to a patient in need thereof, or can be used to identify antagonists of 5-HT6 receptors by well known screening methodologies which could themselves be used in the treatment of mental disorders.
已鉴定出对 5-HT6 受体具有更强亲和力和选择性的化合物。这些化合物可以通过药理学上可接受的给药途径用于治疗精神障碍,也可以通过众所周知的筛选方法确定 5-HT6 受体的拮抗剂,这些拮抗剂本身也可用于治疗精神障碍。